MedPlus pauses integrated diagnostics push, pivots to smaller labs in Chennai and Bengaluru
MedPlus Health Services has shelved its integrated diagnostics model after slower-than-expected subscriber growth in Hyderabad. It will instead open standalone labs costing ₹5 crore-₹6 crore each in Chennai and Bengaluru, while retaining its target of 800 pharmacy stores by year-end.
What happened
MedPlus Health Services · MedPlus paused its integrated diagnostics rollout after Hyderabad subscriber growth lagged, shifting to standalone labs in Chennai and
Key facts
- Standalone lab investment: ₹5 crore-₹6 crore each
- Store target: 800 by year-end
- Hyderabad diagnostics network cost: ₹110 crore-₹120 crore
- Hyderabad addressable population: 10 million
- Subscriber target: 5 lakh paying at least ₹1,000 annually
- Potential annual subscriber revenue: ₹50 crore
- Current diagnostics customers: around 2.2 lakh
- MedPlus share price: ₹655.40
- Market capitalisation: ₹7,869.58 crore
- Shares declined more than 19% over the past year
- Cold-pressed oil sales potential: over 2 lakh bottles per month
Why this matters
MedPlus’s retreat from integrated diagnostics, concierge and wellness creates partnership or acquisition openings in standalone lab networks and pharmacy-linked diagnostic services.
What to watch
- Number and location of new lab openings in Chennai and Bengaluru versus a broader multi-city rollout.
- Diagnostic test volumes, repeat-customer rates, home-sample-collection adoption and lab turnaround times.
- Any introduction of pharmacy-lab bundles, membership offers, corporate packages or insurer tie-ups.
- Progress toward 800 pharmacy stores by year-end and evidence that new stores are concentrated around lab catchments.
- Changes in capex guidance, lease commitments, hiring for diagnostics, or renewed investment in concierge and wellness offerings.
- Competitive responses from Apollo Diagnostics, Dr Lal PathLabs, Metropolis, Thyrocare and pharmacy chains in the two target cities.
- Open a limited number of ₹5 crore-₹6 crore standalone diagnostic labs in Chennai and Bengaluru, likely near dense pharmacy clusters.
- Bundle pathology tests, preventive-health packages and medicine discounts with MedPlus pharmacy loyalty programs rather than revive a full subscription-led integrated-care offering.
- Prioritize pharmacy-store additions, cluster density, supply-chain utilization and private-label penetration to meet the 800-store target.
- Seek partnerships with local hospitals, clinicians, insurers or corporate-health clients to improve lab sample volumes without major new service-line investment.
- Keep paused ventures off the near-term capex plan and reassess them only after pharmacy and lab unit economics stabilize.